![](/wp-content/themes/yootheme/cache/f1/Michigan-f1d2f559.jpeg)
Local Cdiff information for Michigan
Michigan
Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Michigan.
Local Cdiff information for Michigan
Michigan
Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Michigan.
![](/wp-content/themes/yootheme/cache/f1/Michigan-f1d2f559.jpeg)
Providers
Dr. Teena Chopra, MD, MPH
Professor, Infectious Diseases, Wayne State University; Corporate Medical Director of Infection Prevention and Hospital Epidemiology and Antibiotic Stewardship, DMC and WSU
Detroit Medical Center, Wayne State University
4201 St Antoine
Detroit, 48201
313-745-4210
FMT Provider: Yes
Dr. John Yung-Chong Kao, MD
Professor, Internal Medicine
Gastroenterology Clinic Taubman Center
1500 E Medical Center Dr
Floor 3, Reception D
Ann Arbor, 48109
(888) 229-7408
FMT Provider: Yes
Regulation
C. diff Infections
Total Reported Cases: 9470
Hospital Onset: 4546
Community Onset: 4924
Related Deaths: Not reported
Available Reports
State Reporting Laws
Data Submission Required: No
Data Publicly Available: Yes
Data Validated: Yes
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
State Contact
Brenda Brennan, MSPH
HAI Coordinator / SHARP Unit Manager, Surveillance for Healthcare-Associated and Resistant Pathogens (SHARP) Unit
Michigan Department of Health and Human Services
Capitol View Building, 5th floor
201 Townsend, 5th Floor
Lansing, 48913
(517) 284-4945
(517) 335-8263
CLINICAL TRIALS
DSM 33864
Official Title: A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Tolerability and Effect of Bacillus Velezensis DSM 33864 on the Reduction of Risk of Recurrent Clostridioides Difficile Infection (rCDI) in Adults With a History of rCDI
Trial No. NCT05606159
Type: Interventional
Recruitment: Not Yet Recruiting
Sponsor: Novozymes A/S
Contact: Victoria Oyedokun, PhD
+491723244702
Gender: All
Age: 18 Years and older
FMT National Registry
Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
Gender: All
Age: All ages
OpTION
Official Title: CSP #596 – Optimal Treatment for Recurrent Clostridium Difficile Infection
Trial No. NCT02667418
Type: Interventional
Recruitment: Recruiting
Sponsor: VA Office of Research and Development
Contact: Michelle Johnson
(708) 202-8387 ext 27001
Gender: All
Age: 18 Years and older
ROAR
Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact: Global Clinical Compliance
833-548-1402
Gender: All
Age: 18 Years and older
RESTORATiVE303
Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.